SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-010730
Filing Date
2017-04-21
Accepted
2017-04-21 16:31:37
Documents
2
Period of Report
2017-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7954
2 EX-24 DOCUMENT attachment1.htm EX-24 4692
  Complete submission text file 0000899243-17-010730.txt   13992
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Dylan-Hyde Tyler (Reporting) CIK: 0001682027 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 17776273